Cargando…
Naoxintong/PPARα Signaling Inhibits H9c2 Cell Apoptosis and Autophagy in Response to Oxidative Stress
Naoxintong (NXT) is an empirical formula based on the principle of traditional Chinese medicine, which has been approved by China Food and Drug Administration (CFDA) and is widely used for treatment of patients with cerebrovascular and cardiovascular diseases in China. The aim of this study is to in...
Autores principales: | Xu, Huimin, Jin, Jianhua, Chen, Lu, Li, Chunxiao, Xu, Qinggang, Shi, Juanjuan, Zhao, Buchang, Hou, Yongzhong, Wang, Hong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5030446/ https://www.ncbi.nlm.nih.gov/pubmed/27668004 http://dx.doi.org/10.1155/2016/4370381 |
Ejemplares similares
-
Naoxintong/PPARγ Signaling Inhibits Cardiac Hypertrophy via Activation of Autophagy
por: Yuan, Shuping, et al.
Publicado: (2017) -
Naoxintong Retards Atherosclerosis by Inhibiting Foam Cell Formation through Activating PPARα Pathway
por: Wang, Zeng, et al.
Publicado: (2018) -
PPARα induces cell apoptosis by destructing Bcl2
por: Gao, Jiaming, et al.
Publicado: (2015) -
PPARα Enhances Cancer Cell Chemotherapy Sensitivity by Autophagy Induction
por: You, Mengli, et al.
Publicado: (2018) -
NaoXinTong Inhibits the Development of Diabetic Retinopathy in db/db Mice
por: Liu, Mengyang, et al.
Publicado: (2015)